LPL Financial
MYGN icon

LPL Financial’s Myriad Genetics MYGN Stock Holding History

LPL Financial’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,743
Closed -$254K – 3227
2018
Q4 		$254K Buy
8,743
+2,038
+30% +$73.3K ﹤0.01% 2602
2018
Q3 		$308K Sell
6,705
-621
-8% -$27.6K ﹤0.01% 2671
2018
Q2 		$274K Sell
7,326
-1,706
-19% -$57.6K ﹤0.01% 2734
2018
Q1 		$267K Buy
9,032
+2,454
+37% +$83K ﹤0.01% 2731
2017
Q4 		$226K Buy
+6,578
New +$222K ﹤0.01% 2718
2016
Q2 		– Sell
-8,074
Closed -$305K – 2850
2016
Q1 		$305K Buy
8,074
+1,020
+14% +$38.4K ﹤0.01% 2498
2015
Q4 		$302K Buy
+7,054
New +$298K ﹤0.01% 2532
2015
Q2 		– Sell
-8,933
Closed -$311K – 2915
2015
Q1 		$311K Sell
8,933
-32,993
-79% -$1.18M ﹤0.01% 2219
2014
Q4 		$1.43M Sell
41,926
-34,018
-45% -$1.21M 0.01% 1080
2014
Q3 		$2.91M Buy
75,944
+27,736
+58% +$1.03M 0.02% 680
2014
Q2 		$1.88M Buy
48,208
+3,818
+9% +$142K 0.01% 923
2014
Q1 		$1.52M Buy
44,390
+13,666
+44% +$423K 0.01% 995
2013
Q4 		$645K Buy
+30,724
New +$777K ﹤0.01% 1550

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LPL Financial's MYGN Position: Q1 2019 in Review

LPL Financial sold out of Myriad Genetics (MYGN) in Q1 2019, closing a stake of 8,743 shares — an estimated $254K sold.

LPL Financial first reported a position in MYGN in Q4 2013 and held it in 13 quarters. The position peaked at $2.91M in Q3 2014. 262 funds tracked by Wall St. Rank hold MYGN as of Q1 2019.

  • LPL Financial reported no remaining Myriad Genetics position as of Q1 2019 after selling out during the quarter.
  • LPL Financial sold 8,743 Myriad Genetics shares in Q1 2019, an estimated $254K.
  • LPL Financial first reported a position in Myriad Genetics in Q4 2013 and held it in 13 quarters.
  • LPL Financial's Myriad Genetics position peaked at $2.91M in Q3 2014.
  • 262 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2019.

Based on LPL Financial's 13F filing for Q1 2019, filed 8 May 2019.